Ayôla Akim Adégnika
Researcher Next ID · RN-029360
Researcher · Medicine
Tübingen, Luxembourg
- Works count
- 382
- Citation count
- 10,753
- H-index
- 54
- i10-index
- 208
Research interests
Publications
Human schistosomiasis
The Lancet · 2025 · https://doi.org/10.1016/s0140-6736(24)02814-9
Codiversification of gut microbiota with humans
Science · 2022 · https://doi.org/10.1126/science.abm7759
Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies
Immunity · 2017 · https://doi.org/10.1016/j.immuni.2017.11.007
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1513137
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.
The Lancet · 2015 · https://doi.org/10.15496/publikation-6508
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1502924
Schistosomes Induce Regulatory Features in Human and Mouse CD1dhi B Cells: Inhibition of Allergic Inflammation by IL-10 and Regulatory T Cells
PLoS ONE · 2012 · https://doi.org/10.1371/journal.pone.0030883
Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination
Molecular & Cellular Proteomics · 2011 · https://doi.org/10.1074/mcp.m111.014563
Placental Malaria Increases Malaria Risk in the First 30 Months of Life
Clinical Infectious Diseases · 2008 · https://doi.org/10.1086/591968
Fosmidomycin‐Clindamycin for the Treatment ofPlasmodium falciparumMalaria
The Journal of Infectious Diseases · 2004 · https://doi.org/10.1086/424603
Fosmidomycin for malaria
The Lancet · 2002 · https://doi.org/10.1016/s0140-6736(02)11860-5
Current projects
No projects listed.